Thanks for waiting: Vical (VICL) and Curis (CRIS) soar on good news
Today's Financial News - Posted September 3, 2009
Vical (NASDAQ:VICL), Curis (NASDAQ:CRIS), and Tianyin Pharmaceutical Co. Inc. (AMEX:TPI) are making big moves today, lining our HSC members’ pockets with cold, hard cash
by J. Christoph Amberger
Baltimore, MD — TFN: We had a spontaneous outburst of exuberance this morning. TFN’s Laura Cadden was celebrating the stellar jump of her two Hot Stock Confidential picks Vical (NASDAQ:VICL) and Curis (NASDAQ:CRIS).
TFN
VICL hit new record highs when it announced it had received a new U.S. patent covering its Vaxfectin-formulated DNA vaccines for seasonal and pandemic influenza. (They’re currently developing Vaxfectin-formulated DNA vaccines for both H5N1 (avian) and H1N1 (swine) flu.
Her pick of CRIS moved up 20% after the company announced that GDC-0449, an experimental cancer medicine developed by Genentech and Curis, actually works in shrinking tumors by targeting the gene-associated “hedgehog” pathway.
It was a relief: “I thought I’d die yesterday when the stocks went down,” Laura said.
The reason for her mental unease: We had actively decided not to implement a stop loss when shares went past the 30% gain we had expected. Last week, when we were itching to take what now looks like “modest” profits on these stocks, we decided to throw caution to the wind and told you to “Cool your heels on Vical“.
It paid off nicely. HSC Member Michael M. emailed us: “Continuing the subject of volatile stock prices ( VICL in particular ), I would like to suggest a more descriptive term than ’stop loss’. I will now call it the ‘Threshold of Pain’. Congratulations first to you for your selection of this stock and to all of us who endured the pain for the 40% + gain!!!!! On to the next one and THANK YOU!!”
Of course, we now faced the same problem, just at a higher price: Sell now? Or establish a stop loss? Or hold on for more gains, without safety net?
“If you put a stop loss in, it’ll hit it,” said Andy Snyder.
It’s a good quandary to have: To sell and bank gains over 40%… or hold on for more.
And it isn’t just VICL we’re contemplating!
We’ve decided that in this situation, the best option is to have our cake and eat it, too: Bank the gains on half of each position in question and letting the rest ride:
Laura sent out an email alert to our HSC friends instructing to:
“* Sell half your shares of Curis Inc. (NASDAQ:CRIS) for around 50% gains
“* Sell half your shares of Tianyin Pharmaceutical Co. Inc. (AMEX:TPI) for around 53% gains
“* Sell half your shares of Vical Inc. (NASDAQ:VICL) for around 50% gains
“And hold onto the other half for what we hope will be even greater gains!”
Here’s what another HSC Member, Matthew W., had to say about that: It’s great to be back. I signed for the year, the info you lot provide is worth a heap, and that is not including the picks.”
But Laura isn’t one to leave good enough alone. For today’s HSC alert, she has analyzed 5 stocks suggested by our members. The competiton is on: Our members are a sharp bunch… what if they do better than our editors?
(By the way, TPI was one of our “Proxy Stocks”… check out if you agree with our line of argument.
Next Article: Midas touch: Rising gold prices guide Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Hecla Mining (HL) to strong gains
Be the first to leave a reply.
Your comments are welcome
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down